QQQ   350.63 (+0.76%)
AAPL   179.59 (+1.32%)
MSFT   330.11 (+0.52%)
META   269.67 (+1.87%)
GOOGL   123.15 (+0.23%)
AMZN   122.29 (+1.42%)
TSLA   204.68 (+0.37%)
NVDA   393.72 (+4.07%)
NIO   7.49 (-0.53%)
BABA   83.34 (+4.76%)
AMD   119.17 (+0.81%)
T   15.82 (+0.57%)
F   12.08 (+0.67%)
MU   68.81 (+0.89%)
CGC   0.85 (+1.69%)
GE   104.65 (+3.07%)
DIS   88.43 (+0.53%)
AMC   4.60 (+2.22%)
PFE   38.15 (+0.34%)
PYPL   62.96 (+1.56%)
NFLX   400.38 (+1.30%)
QQQ   350.63 (+0.76%)
AAPL   179.59 (+1.32%)
MSFT   330.11 (+0.52%)
META   269.67 (+1.87%)
GOOGL   123.15 (+0.23%)
AMZN   122.29 (+1.42%)
TSLA   204.68 (+0.37%)
NVDA   393.72 (+4.07%)
NIO   7.49 (-0.53%)
BABA   83.34 (+4.76%)
AMD   119.17 (+0.81%)
T   15.82 (+0.57%)
F   12.08 (+0.67%)
MU   68.81 (+0.89%)
CGC   0.85 (+1.69%)
GE   104.65 (+3.07%)
DIS   88.43 (+0.53%)
AMC   4.60 (+2.22%)
PFE   38.15 (+0.34%)
PYPL   62.96 (+1.56%)
NFLX   400.38 (+1.30%)
QQQ   350.63 (+0.76%)
AAPL   179.59 (+1.32%)
MSFT   330.11 (+0.52%)
META   269.67 (+1.87%)
GOOGL   123.15 (+0.23%)
AMZN   122.29 (+1.42%)
TSLA   204.68 (+0.37%)
NVDA   393.72 (+4.07%)
NIO   7.49 (-0.53%)
BABA   83.34 (+4.76%)
AMD   119.17 (+0.81%)
T   15.82 (+0.57%)
F   12.08 (+0.67%)
MU   68.81 (+0.89%)
CGC   0.85 (+1.69%)
GE   104.65 (+3.07%)
DIS   88.43 (+0.53%)
AMC   4.60 (+2.22%)
PFE   38.15 (+0.34%)
PYPL   62.96 (+1.56%)
NFLX   400.38 (+1.30%)
QQQ   350.63 (+0.76%)
AAPL   179.59 (+1.32%)
MSFT   330.11 (+0.52%)
META   269.67 (+1.87%)
GOOGL   123.15 (+0.23%)
AMZN   122.29 (+1.42%)
TSLA   204.68 (+0.37%)
NVDA   393.72 (+4.07%)
NIO   7.49 (-0.53%)
BABA   83.34 (+4.76%)
AMD   119.17 (+0.81%)
T   15.82 (+0.57%)
F   12.08 (+0.67%)
MU   68.81 (+0.89%)
CGC   0.85 (+1.69%)
GE   104.65 (+3.07%)
DIS   88.43 (+0.53%)
AMC   4.60 (+2.22%)
PFE   38.15 (+0.34%)
PYPL   62.96 (+1.56%)
NFLX   400.38 (+1.30%)
NASDAQ:ADXS

Ayala Pharmaceuticals (ADXS) Stock Forecast, Price & News

$1.14
-0.06 (-5.00%)
(As of 12:03 PM ET)
Compare
Today's Range
$1.13
$1.18
50-Day Range
N/A
52-Week Range
$0.65
$7.20
Volume
2,009 shs
Average Volume
7,598 shs
Market Capitalization
$2.07 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Ayala Pharmaceuticals

Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ.

Receive ADXS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ayala Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ADXS Stock News Headlines

See More Headlines

ADXS Price History

ADXS Company Calendar

Today
6/01/2023
Fiscal Year End
10/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ADXS
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-14,360,000.00
Pretax Margin
-578,049.94%

Debt

Sales & Book Value

Annual Sales
$250,000.00
Book Value
$5.33 per share

Miscellaneous

Free Float
1,810,000
Market Cap
$2.18 million
Optionable
Not Optionable
Beta
2.44

Key Executives

  • Ken Berlin
    President, Chief Executive Officer & Director
  • Igor Gitelman
    VP-Finance, Chief Financial & Accounting Officer
  • Andres A. Gutiérrez
    Chief Medical Officer & Executive Vice President
  • Michael Grace
    Vice President-Technical Operations













ADXS Stock - Frequently Asked Questions

How have ADXS shares performed in 2023?

Ayala Pharmaceuticals' stock was trading at $0.99 on January 1st, 2023. Since then, ADXS stock has increased by 21.2% and is now trading at $1.20.
View the best growth stocks for 2023 here
.

What other stocks do shareholders of Ayala Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ayala Pharmaceuticals investors own include Inovio Pharmaceuticals (INO), Madrigal Pharmaceuticals (MDGL), Merck & Co., Inc. (MRK), Anavex Life Sciences (AVXL), VistaGen Therapeutics (VTGN), Novavax (NVAX), Highpower International (HPJ), OPKO Health (OPK) and Athersys (ATHX).

What is Ayala Pharmaceuticals' stock symbol?

Ayala Pharmaceuticals trades on the NASDAQ under the ticker symbol "ADXS."

How do I buy shares of Ayala Pharmaceuticals?

Shares of ADXS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Ayala Pharmaceuticals' stock price today?

One share of ADXS stock can currently be purchased for approximately $1.20.

How much money does Ayala Pharmaceuticals make?

Ayala Pharmaceuticals (NASDAQ:ADXS) has a market capitalization of $2.18 million and generates $250,000.00 in revenue each year. The company earns $-14,360,000.00 in net income (profit) each year or ($8.93) on an earnings per share basis.

How can I contact Ayala Pharmaceuticals?

Ayala Pharmaceuticals' mailing address is 9 DEER PARK DRIVE SUITE K-1, MONMOUTH JUNCTION NJ, 08852. The official website for the company is www.ayalapharma.com. The company can be reached via phone at (609) 452-9813, via email at ir@ayalapharma.com, or via fax at 609-452-9818.

This page (NASDAQ:ADXS) was last updated on 6/1/2023 by MarketBeat.com Staff

My Account -